NIH

Seven plucky diagnostics companies win a $249M round of contracts after surviving NIH's Covid-19 'Shark Tank' competition
Seven plucky diagnostics companies win a $249M round of contracts after surviving NIH's Covid-19 'Shark Tank' competition
Endpoints
diagnostics
COVID-19
NIH
RADx
pandemic
Quidel
Mesa Biotech
Talis Biomedical
Ginkgo Bioworks
Helix OpCo
Fluidigm
Mammoth Biosciences
Flag link:
Medical researchers sign open letter calling for COVID-19 human challenge trials
Medical researchers sign open letter calling for COVID-19 human challenge trials
Beckers Hospital Review
NIH
pandemic
vaccines
COVID-19
clinical trials
Flag link:
NIH rolls out COVID-19 clinical trials network: 5 things to know
NIH rolls out COVID-19 clinical trials network: 5 things to know
Beckers Hospital Review
clinical trials
NIH
COVID-19
pandemic
COVID-19 Prevention Trials Network
Flag link:
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
MedCity News
Gilead Sciences
remdesivir
NIH
COVID-19
Flag link:
Former Sanofi research exec Zerhouni favorite for COVID-19 czar: report
Former Sanofi research exec Zerhouni favorite for COVID-19 czar: report
Fierce Biotech
COVID-19
vaccines
NIH
Sanofi
Elias Zerhouni
Flag link:
Inside the NIH’s controversial decision to stop its big remdesivir study
Inside the NIH’s controversial decision to stop its big remdesivir study
Stat
Gilead Sciences
remdesivir
NIH
clinical trials
COVID-19
pandemic
Flag link:
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe
Endpoints
Gilead Sciences
remdesivir
COVID-19
EMA
NIH
FDA
Europe
Flag link:
A COVID-19 treatment inspired by llamas
A COVID-19 treatment inspired by llamas
Fierce Biotech
COVID-19
antibodies
drug development
nanobodies
NIH
animal research
Flag link:
BARDA director abruptly departs agency tasked with leading nation's vaccine development
BARDA director abruptly departs agency tasked with leading nation's vaccine development
BioPharma Dive
vaccines
COVID-19
BARDA
NIH
Flag link:
NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines
NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines
Stat
NIH
vaccines
drug development
pandemic
COVID-19
R&D
Flag link:
Simply speaking could transmit coronavirus, new study suggests
Simply speaking could transmit coronavirus, new study suggests
Stat
NIH
COVID-19
pandemic
epidemiology
Flag link:
Eli Lilly teams with NIH, antibody upstart AbCellera in coronavirus hunt
Eli Lilly teams with NIH, antibody upstart AbCellera in coronavirus hunt
Endpoints
Eli Lilly
NIH
AbCellera
coronaviruses
COVID-19
vaccines
R&D
Flag link:
To develop a coronavirus vaccine, synthetic biologists try to outdo nature
To develop a coronavirus vaccine, synthetic biologists try to outdo nature
Stat
Gates Foundation
NIH
vaccines
coronaviruses
COVID-19
synthetic biology
Flag link:
US cancels trial after finding vaccine doesn't prevent HIV
US cancels trial after finding vaccine doesn't prevent HIV
BioPharma Dive
South Africa
NIH
vaccines
HIV
Flag link:
Moderna, federal researchers kick off vaccine work against deadly new coronavirus
Moderna, federal researchers kick off vaccine work against deadly new coronavirus
Fierce Pharma
Moderna Therapeutics
MRNA
Wuhan Coronavirus
vaccines
NIH
Flag link:
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Flag link:
Will sky-high drug prices spur the US to use an obscure power over patents?
Will sky-high drug prices spur the US to use an obscure power over patents?
Biopharma Dive
drug pricing
patents
NIH
Flag link:
ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment
ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment
Pharmaceutical Business Review
HIV
NIH
ViiV Healthcare
HIV-1
drug discovery
Flag link:
Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach
Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach
Fierce Biotech
T3D Therapeutics
NIH
Alzheimer's disease
Flag link:
NIH, Gates Foundation commit $200M to cure HIV, sickle cell
NIH, Gates Foundation commit $200M to cure HIV, sickle cell
Fierce Biotech
NIH
Gates Foundation
HIV
sickle cell disease
Flag link:

Pages